About Swing Therapeutics
Swing Therapeutics is a private company based in San Francisco, California. It has reported $30,862,705 raised in three offerings on Form D since July 2022. Its chief executive is Michael Rosenbluth.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 28, 2025 | Aug 29, 2025 | $11,377,712of $14.5M target | 14 | $812K | Equity, OptionsRule 506(b) | Form D ↗ |
| Jan 24, 2022 | Jul 26, 2022 | $10,294,993of $12.4M target | 11 | $935K | EquityRule 506(b) | Form D ↗ |
| Aug 7, 2019 | Jul 26, 2022 | $9,190,000of $9.2M target | 5 | $1.8M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $30,862,705 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Swing Therapeutics's Form D filed Aug 29, 2025.
CM
Corey McCann
Director
AF
Andrew Firlik
Director
MR
Michael Rosenbluth
Chief Executive Officer and director
ZL
Zack Lynch
Director